I[ntroduction]{.smallcaps} {#sec1-1}
==========================

The Acute Physiology and Chronic Health Evaluation Score (APACHE\[[@ref1]\]) came into use after its publication in the early 1980s. Since then, severity of illness scoring systems has gained increasing popularity in Intensive Care Units (ICUs). Physicians used them for predicting mortality and for assessing illness severity in clinical trials. Among these systems, the APACHE, Simplified Acute Physiology Score (SAPS\[[@ref2]\]), and mortality prediction model\[[@ref3]\] are most widely used scoring systems.

Le Gall *et al*.\[[@ref2]\] developed the SAPS by simplifying the APACHE. To adapt to the clinical setting, the SAPS evolves into its third version (SAPS 3\[[@ref4][@ref5]\]). The successor provides physicians with customized equations for different regions of the world, which would improve the accuracy for predicting mortality probability. SAPS 3 is widely used both in Europe and America in the ICUs while relevant evidence is absent in China as in clinical practice. Thus, the objective of the study was to assess the performance of SAPS 3 in predicting clinical prognosis and hospital mortality in emergency ICU (EICU).

Participants were graded by SAPS 3 admission score, the approach of which is complemented by the development of specific customized equations for major areas of the world. The overall discriminatory capability of the model was measured by receiver operating characteristic (ROC) curve. Hosmer-Lemeshow goodness-of-fit test was adopted to assess the quality of predictions in the validation sets.

M[ethods]{.smallcaps} {#sec1-2}
=====================

Ethical approval {#sec2-1}
----------------

The study was conducted in accordance with the *Declaration of Helsinki* and was approved by the local ethics committee of the institute. Informed written consent was obtained from all patients prior to their enrollment in this study.

Participants {#sec2-2}
------------

This study was performed at the EICU of Peking University Third Hospital. Four hundred and sixty-three patients admitted to EICU from January 2013 to December 2015 were retrospectively studied, including 257 male and 206 female patients. The average age of participants is 72.1 ± 15.5 years, and all of them suffered from internal diseases. Patients \<18 years old, with ICU stay \<24 h or missing components for SAPS 3 analysis, were excluded from the study. Other exclusion criteria include treatment of mild hypothermia therapy. Only the first ICU admission of patients with multiple ICU admissions during a single hospital stay was considered.

Data collection {#sec2-3}
---------------

Data were collected by reviewing medical records of eligible patients, which include demographic data, surgical interventions, previous comorbidities, main diagnosis for ICU admission, length of stay, and the prognosis. The worst physiological data within 24 h of admission were recorded, such as vital signs, blood routine tests, and Glasgow Coma Scale score. Severity scores (APACHE IV, SAPS 3) were calculated based on clinical and laboratory data collected.

Predicting hospital mortality {#sec2-4}
-----------------------------

Actual mortality rates of the sample were calculated. Predicted hospital mortalities were calculated using the general SAPS 3 and the customized AUS-SAPS3 equations as follows: logit = −32.6659 + ln (SAPS 3 score + 20.5958) × 7.3068, logit = 22.5717 + ln (SAPS 3 score + 1) × 5.3163 for Australasia SAPS 3 admission scores (AUS-SAPS3) and the probability of death = elogit/(1 + elogit).\[[@ref4]\]

Statistical analysis {#sec2-5}
--------------------

We used SPSS software version 19.0 (IBM corp., NY, USA) to perform the statistical analysis. Continuous variables were presented as mean ± standard deviation (SD) or median (interquartile range), relationships between groups were analyzed with Student\'s *t*-test or rank test. Kolmogorov-Smirnov tests were used for normality test. Chi-squared tests were adopted for comparing ratios. Multivariate logistic regression was performed to identify independent factors associated with hospital mortality. A two-tailed *P* \< 0.05 was considered statistically significant. To evaluate prognostic performance of different models, the following tools were used: discrimination - capability of the model to distinguish between patients who die from patients who survive was evaluated, which was tested by measuring the area (area under the curve, \[AUC\]) under the ROC curve.\[[@ref6]\] ROC curve is constructed by plotting the 1-specificity against sensitivity. Youden index, along with sensitivity and specificity, was obtained from the curve. *Z*-test was used to compare the AUC. The sensitivity is the proportion of patients who died that was predicted correctly by the model. Specificity refers to the proportion of true negatives. Youden index is a single statistic that captures the performance of a diagnostic test. J = Sensitivity + Specificity − 1. Its value ranges from −1 to 1. A value of 1 indicates that there are no false positives or false negatives, i.e., the test is perfect.

**Calibration**

Reliability of the system can be quantified in terms of calibration, which represents the level of accordance between observed and predicted probabilities of the outcome. This is usually derived from Hosmer-Lemeshow goodness-of-fit test, which is a statistical test for logistic regression models. The H-statistic is based on fixed cut points on the predictions such as the deciles of risk whereas the C-statistic is based on equally sized groups, based on probability of death. Notably, the Hosmer-Lemeshow test indicates that goodness-of-fit is fairly good when *P* \> 0.05.\[[@ref7][@ref8]\]

**Standardized mortality ratio**

Standardized mortality ratio (SMR) corresponding to the ratio predicted mortality/mortality observed\[[@ref9]\] was calculated for scoring systems. Confidence intervals (*CI*s) for the SMRs were calculated using a 95% confidence limit.\[[@ref10]\] If the SMR is equal to 1.0, this means the number of observed deaths equals that of expected cases. If higher than 1.0, there is a lower number of deaths than is expected. The equation for the lower limit is as follows:
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The equation for the upper limit is as follows:
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R[esults]{.smallcaps} {#sec1-3}
=====================

Main patients' demographic and clinical characteristics are shown in [Table 1](#T1){ref-type="table"}. During the study period, there were 463 patients admitted to the ICU. The median age was 72.1 ± 15.5 years. Median length of ICU stay was 16 (8.8--29.0) days. Respiratory and cardiovascular diseases were the most frequent organ-specific indications for ICU admission. In-hospital mortality was 26.1% (121/463). [Table 2](#T2){ref-type="table"} presents the performance of survivors and nonsurvivors. The age, SAPS 3 score, APACHE II score, and predicted mortality were all significantly greater in nonsurvivors than survivors (*P* \< 0.05 or *P* \< 0.01). There were significant difference in severe pneumonia, acute exacerbation of chronic obstructive pulmonary disease, interstitial lung disease, sudden death and septic shock between two groups, which indicated that respiratory and cardiovascular failure might account for most of the deaths.

###### 

Basic demographic and clinical characteristics

  Variables                              Characteristics
  -------------------------------------- -----------------
  Age (years)                            72.1 ± 15.5
  Male                                   257 (55.5)
  Main diagnosis for ICU admission       
   Respiratory diseases                  228 (49.2)
    Severe pneumonia                     115 (24.8)
    AECOPD                               56 (12.1)
    Bronchiectasis                       15 (3.2)
    Bronchial asthma                     10 (2.2)
    Interstitial lung disease            8 (1.7)
    Pulmonary embolism                   7 (1.5)
    Lung cancer                          5 (1.1)
    Other                                12 (2.6)
   Circulation system diseases           141 (30.5)
    Heart failure                        46 (9.9)
    Sudden death                         34 (7.3)
    Coronary heart disease               28 (6.0)
    Septic shock                         24 (5.2)
    Other                                9 (1.9)
   Digestive system diseases             31 (6.7)
    Gastrointestinal bleeding            13 (2.8)
    Acute pancreatitis                   11 (2.4)
    Gastrointestinal infections          5 (1.1)
    Other                                2 (0.4)
   Urinary system diseases               24 (5.2)
    Kidney failure                       20 (4.3)
    Urinary infection                    4 (0.9)
   Drug intoxication                     15 (3.2)
   Nervous system disease                11 (2.4)
   Acute complications of diabetes       9 (1.9)
   Other                                 4 (0.9)
   Mechanical ventilation on admission   
    Invasive mechanical ventilation      191 (41.3)
    Noninvasive mechanical ventilation   109 (23.5)
    No mechanical ventilation            163 (35.2)
    Hospital length of stay (days)       16 (8.8--29.0)
    SAPS 3 scores                        61 (53--72)
    APACHE II scores                     13 (9--18)
    Hospital mortality                   121 (26.1)

Data are presented as mean ± SD or *n* (%) or median (interquartile range). AECOPD: Acute exacerbation of chronic obstructive pulmonary disease; APACHE II: Acute Physiology and Chronic Health Evaluation Score II; SAPS 3: Simplified Acute Physiology Score 3; ICU: Intensive Care Unit; SD: Standard deviation.

###### 

Performance of survivors and nonsurvivors

  Items                                Survivors (*n* = 342)   Nonsurvivors (*n* = 121)   *P*
  ------------------------------------ ----------------------- -------------------------- ---------
  Age, (years)                         69.8 ± 16.2             78.6 ± 10.8                \<0.001
  Male                                 185                     72                         0.303
  Length of stay (days)                16 (9--28)              18 (7--35)                 0.960
  Main diagnosis for ICU admission                                                        
   Respiratory disease                                                                    
    Severe pneumonia                   74 (21.6)               41 (33.9)                  0.007
    AECOPD                             49 (14.3)               7 (5.8)                    0.013
    Bronchiectasis                     14 (4.1)                1 (0.8)                    0.148
    Bronchial asthma                   10 (2.9)                0                          0.124
    Interstitial lung disease          0                       7 (5.8)                    \<0.001
    Pulmonary embolism                 7 (2.0)                 0                          0.249
    Lung cancer                        2 (0.6)                 3 (2.5)                    0.222
   Circulation system diseases                                                            
    Heart failure                      35 (10.2)               11 (9.1)                   0.718
    Sudden death                       18 (5.3)                16 (13.2)                  0.004
    Coronary heart disease             21 (6.1)                7 (5.8)                    1.000
    Septic shock                       11 (3.2)                16 (13.2)                  \<0.001
   Digestive system diseases                                                              
    Gastrointestinal bleeding          10 (2.9)                3 (2.5)                    1.000
    Acute pancreatitis                 10 (2.9)                1 (0.8)                    0.340
    Gastrointestinal infections        5 (1.5)                 0                          0.409
   Urinary system diseases                                                                
    Kidney failure                     18 (5.3)                2 (1.7)                    0.093
    Urinary infection                  2 (0.6)                 2 (1.7)                    0.603
   Drug intoxication                   14 (4.1)                1 (0.8)                    0.148
   Nervous system disease              8 (2.3)                 3 (2.5)                    1.000
   Acute complications of diabetes     9 (2.6)                 0                          0.156
  SAPS 3 scores                        57 (51.0--65.3)         75 (66.5--83.5)            \<0.001
  APACHE II scores                     11 (8--16)              18 (13--25)                \<0.001
  APACHE II predicted mortality (%)    10.6 (5.9--20.8)        32.2 (16.5--56.9)          \<0.001
  SAPS 3 predicted mortality (%)       30 (19.0--46.5)         66 (49--79)                \<0.001
  AUS-SAPS 3 predicted mortality (%)   27.2 (17.3--43.1)       61.1 (45.5--73.4)          \<0.001

Data are presented as mean ± SD or *n* (%) or median (interquartile range). SAPS 3: Simplified Acute Physiology Score 3; AUS-SAPS3: Australasia-SAPS 3; APACHE II: Acute Physiology and Chronic Health Evaluation Score II; AECOPD: Acute exacerbation of chronic obstructive pulmonary disease; SD: Standard deviation; ICU: Intensive Care Unit.

Performances of the models are summarized in [Table 3](#T3){ref-type="table"}. The discriminative power, assessed using the AUC, was significantly lower (*Z* = 4.172, *P* \< 0.0001) for the APACHE II model (0.741) as compared with SAPS 3 (0.836). The maximum Youden index of SAPS 3 was 0.526, at which the optimal cutoff was 70.5 points. APACHE II had the Youden index of 0.327 at its most when the optimal cutoff was 17.5 points. Hospital mortality reached 93.1% when SAPS 3 was no \<70.5 points. The ROC curves for scores are shown in [Figure 1](#F1){ref-type="fig"}.

###### 

Comparing the AUC of the SAPS 3 and APACHE II models

  Variables   Score         AUC     95% *CI*       Cutoff   Sensitivity (%)   Specificity (%)   *Z*-test   *P*
  ----------- ------------- ------- -------------- -------- ----------------- ----------------- ---------- ----------
  SAPS 3      61 (53--72)   0.836   0.796--0.876   70.5     66.9              85.7              4.172      \<0.0001
  APACHE II   13 (9--18)    0.741   0.691--0.791   13.5     52.9              79.8                         

AUC: Area under the curve; SAPS 3: Simplified Acute Physiology Score 3; APACHE II: Acute Physiology and Chronic Health Evaluation Score II; *CI*: Confidence interval.

![Receiver operating characteristic curve for Simplified Acute Physiology Score 3 (SAPS3) and Acute Physiology and Chronic Health Evaluation Score II (APACHE2).](CMJ-130-1544-g003){#F1}

The calibration of the SAPS 3 and APACHE II prognostic model: Hosmer-Lemeshow goodness-of-fit test for APACHE II, SAPS 3, and AUS-SAPS3 is shown in [Table 4](#T4){ref-type="table"}. The calculated Chi-square statistics are 4.13 (*P* = 0.91) for APACHE II, 10.25 (*P* = 0.33) for SAPS 3, and 9.55 (*P* = 0.38) for AUS-SAPS3. All *P* values \> 0.05, which indicated goodness-of-fit of the three scores are fairly good. APACHE II models tended to underestimate the hospital mortality (SMR \>1); however, SAPS 3 and AUS-SAPS 3 models tended to overestimate the hospital mortality (both SMR \<1). Calibration curves for APACHE II, SAPS 3, and AUS-SAPS3 are shown in Figures [2](#F2){ref-type="fig"}--[4](#F4){ref-type="fig"}. It is shown from the curves that SAPS 3 and AUS-SAPS 3 models overestimate the hospital mortality at nearly all deciles.

###### 

Comparison of calibration of the SAPS 3 and AUS-SAPS3

  Version                         APACHE II           SAPS 3              AUS-SAPS3
  ------------------------------- ------------------- ------------------- -------------------
  Hosmer-Lemeshow (*χ*^2^, *P*)   4.13 (0.91)         10.25 (0.33)        9.55 (0.38)
  SMR (95% *CI*)                  1.21 (1.00--1.44)   0.63 (0.52--0.76)   0.68 (0.57--0.81)
  Observed mortality rate (%)     26.1                26.1                26.1
  Predicted mortality rate (%)    21.7                41.3                38.3

SMR: Standardized mortality ratio; SAPS 3: Simplified Acute Physiology Score 3; AUS-SAPS3: Australasia SAPS 3; APACHE II: Acute Physiology and Chronic Health Evaluation Score II; *CI*: Confidence interval.

![Calibration curves for Acute Physiology and Chronic Health Evaluation Score II.](CMJ-130-1544-g004){#F2}

![Calibration curves for Simplified Acute Physiology Score 3.](CMJ-130-1544-g005){#F3}

![Calibration curves for Simplified Acute Physiology Score 3 (Australasia).](CMJ-130-1544-g006){#F4}

Analyses were conducted to assess the prognostic scores adjusting for respiratory disease, severe pneumonia, circulation system disease, sudden death, septic shock, and the use of mechanical ventilation on hospital mortality. [Table 5](#T5){ref-type="table"} demonstrates the performance of subgroups sorted by disease. It shows that the SMR was \<1 in all the subgroups, which indicates an overestimated hospital mortality across all subgroups.

###### 

Performance of SAPS 3 for subgroups

  Disease group                *n*   AUC (95% *CI*)         Hosmer-Lemeshow   SMR (95% *CI*)   
  ---------------------------- ----- ---------------------- ----------------- ---------------- -------------------
  Total                        463   0.836 (0.796--0.876)   10.25             0.33             0.63 (0.52--0.76)
  Respiratory disease          228   0.831 (0.771--0.892)   5.77              0.80             0.67 (0.51--0.86)
  Severe pneumonia             115   0.835 (0.757--0.912)   2.98              0.96             0.80 (0.57--1.08)
  Circulation system disease   141   0.851 (0.789--0.913)   4.38              0.85             0.73 (0.54--0.96)
  Sudden death                 34    0.852 (0.727--0.978)   2.32              0.88             0.79 (0.45--1.28)
  Septic shock                 24    0.854 (0.706--1.000)   1.90              1.00             0.82 (0.42--1.43)
  Mechanical ventilation       300   0.785 (0.719--0.851)   5.14              0.85             0.68 (0.55--0.83)
  No mechanical ventilation    163   0.842 (0.765--0.920)   5.86              0.69             0.49 (0.31--0.73)

SMR: Standardized mortality ratio; AUC: Area under the curve; SAPS 3: Simplified Acute Physiology Score 3; *CI*: Confidence interval.

[Table 6](#T6){ref-type="table"} presents the variables that were collected but not included in the SAPS 3 score. Hemoglobin (Hb), hematocrit (HCT), and albumin followed the normal distribution when using the Kolmogorov-Smirnov test. Univariate analysis was performed to identify factors associated with hospital mortality. There was significant difference in procalcitonin, brain natriuretic peptide, D-dimer, troponin I, Hb, blood urea nitrogen (BUN), albumin, lactate, glucose, free triiodothyronine (FT3), free thyroxine (FT4), HCT, and 24 h urine volume between two groups (*P* \< 0.05).

###### 

Biomarkers between survivors and nonsurvivors

  Variables                 Survivors (*n* = 342)        Nonsurvivors (*n* = 121)       *P*
  ------------------------- ---------------------------- ------------------------------ ---------
  PCT (µg/L)                0.45 (0.12--1.90)            1.48 (0.42--6.57)              \<0.001
  BNP (ng/L)                2320.00 (844.00--9150.00)    5960.00 (1452.00--15,375.00)   \<0.001
  D-dimer (mg/L)            0.93 (0.45--2.03)            1.30 (0.70--3.47)              \<0.001
  TnI (µg/L)                0.01 (0.01--0.07)            0.03 (0.01--0.28)              \<0.001
  Hemoglobin (g/L)          109.09 ± 28.20               98.62 ± 24.97                  \<0.001
  BUN (mmol/L)              8.00 (5.20--13.45)           12.00 (7.25--21.10)            \<0.001
  Albumin (g/L)             31.64 ± 6.90                 28.12 ± 5.83                   \<0.001
  Na (mmol/L)               142.00 (138.00--146.00)      141.20 (137.80--148.00)        0.833
  K (mmol/L)                3.94 (3.68--4.40)            4.14 (3.70--4.60)              0.061
  Lactate (mmol/L)          1.10 (0.80--1.70)            1.40 (1.10--2.40)              \<0.001
  Glucose (mmol/L)          6.80 (5.10--9.43)            7.90 (5.40--10.50)             0.020
  FT3 (pmol/L)              1.87 (1.53--2.25)            1.55 (1.23--1.80)              \<0.001
  FT4 (pmol/L)              1.09 (0.93--1.26)            1.01 (0.80--1.18)              0.001
  TSH (mIU/L)               0.73 (0.30--1.73)            0.62 (0.28--1.51)              0.539
  Hematocrit (%)            33.70 ± 9.87                 30.56 ± 7.76                   0.003
  Urine volume (24 h, ml)   1550.00 (1050.00--2412.50)   1450.00 (850.00--2125.00)      0.029
  Length of stay (days)     16.00 (9.00--28.00)          18.00 (7.00--35.00)            0.960

Data are presented as mean ± SD or median (interquartile range). PCT: Procalcitonin; BNP: Brain natriuretic peptide; TnI: Troponin I; BUN: Blood urea nitrogen; FT3: Free triiodothyronine; FT4: Free thyroxine; SD: Standard deviation; TSH: Thyroid-stimulating hormone.

Variables were analyzed using multiple logistic regression analysis. Results are listed in [Table 7](#T7){ref-type="table"}. BUN, albumin, lactate, and FT3 were selected as independent risk factors for prognostic value. The regression coefficients of albumin and FT3 were −0.062 and −0.918, respectively. The odds ratios of albumin and FT3 were 0.940 (95% *CI*: 0.896--0.986) and 0.399 (95% *CI*: 0.232--0.687), respectively, which manifested their protective effect for prognosis. In contrast, the regression coefficients of BUN and lactate were 0.036 and 0.282, with the odds ratios of 1.037 (95% *CI*: 1.010--1.064) and 1.326 (95% *CI*: 1.157--1.519), respectively. BUN and lactate were therefore demonstrated as risk factors for patients. Moreover, higher values were associated with a high risk of death.

###### 

Multiple logistic regression for variables

  Variables   *B*      SE      Wals     df   *P*       *OR*    95% *CI*
  ----------- -------- ------- -------- ---- --------- ------- --------------
  BUN         0.036    0.013   7.524    1    0.006     1.037   1.010--1.064
  Albumin     −0.062   0.024   6.494    1    0.011     0.940   0.896--0.986
  Lactate     0.282    0.069   16.475   1    \<0.001   1.326   1.157--1.519
  FT3         −0.918   0.277   10.991   1    0.001     0.399   0.232--0.687
  Constant    1.375    0.764   3.243    1    0.072     3.955   

BUN: Blood urea nitrogen; FT3: Free triiodothyronine; SE: Standard error; *CI*: Confidence interval; *OR*: Odds ratio.

D[iscussion]{.smallcaps} {#sec1-4}
========================

SAPS 3 is used worldwide in ICUs. Some important differences within the patients might affect outcome. These include, for example, genetic makeups, styles of living, and distribution of major diseases in different regions, as well as availability of the health-care system. While relevant evidence is absent in China at present, in this study, we have conducted a retrospective analysis to verify its prognostic value.

Participants admitted to EICU were mostly aged patients, thus respiratory and circulation system diseases accounted for 80% of all causes. We evaluated the performance of survivors and nonsurvivors: SAPS 3 and APACHE II scores were both significantly greater in nonsurvivors than survivors. Higher severity score was associated with higher hospital mortality. The SAPS 3 demonstrated better discrimination with the AUC (0.836) higher than APACHE II (AUC = 0.741). Besides, its sensitivity and specificity were superior to APACHE II at the optimal cutoff, which also indicted better discrimination. However, the two prognostic models did not showed excellent calibration, and the SAPS 3 scoring system (SMR = 0.63) was not superior to APACHE II (SMR = 1.21) in calibration.

Moreno *et al*.\[[@ref5]\] developed the customized equations for major areas of the world using multilevel logistic regression. AUS-SAPS 3 was developed from a database built from patients in Australasia, India, and Hong Kong.\[[@ref4][@ref5]\] According to the study of Lim *et al*.,\[[@ref11]\] general and regional Australasia SAPS 3 admission scores showed poor calibration for use in Korean ICU patients. However, the prognostic power of the SAPS 3 was significantly improved after country-specific customization. The present study shows that SAPS 3 and AUS-SAPS 3 had excellent calibration (*P* = 0.33 and *P* = 0.38, respectively), yet overestimated hospital mortality (SMR = 0.63 and SMR = 0.68, respectively). The findings are in accordance with previous studies. Furthermore, the calibration has not improved after customizing the logit of the original equation. Similar conclusion can be drawn from another study by Lim *et al*.\[[@ref12]\] We came up with two explanations. First, the AUS-SAPS 3 equation was derived from data collected from 1756 patients from Australia (*n* = 651), India (*n* = 532), and Hong Kong (*n* = 573). There are likely to be vast differences stemming from variability in genetic makeups, styles of living, and distribution of major diseases. Second, all participants suffered from internal disease at our center, whereas SASP 3 was built on multicenter and multinational cohort study. That means the disease spectrum is more diverse. Moreover, during the retrospective analysis in the EICU, biomarkers were recorded as the worst value in the first 24-h period rather than the value within 1 h on admission, which might contribute to the overestimation of the hospital mortality.

We also analyzed prognostic power of the SAPS 3 for various subgroups, including respiratory disease, severe pneumonia, circulation system disease, sudden death, septic shock, and the use of mechanical ventilation. Except for the patients on mechanical ventilation, all the subgroups demonstrated excellent discrimination (AUC all \>0.8). It can be concluded from above that SAPS 3 is good at distinguishing between nonsurvivors and survivors. Moreover, all subgroups showed fair calibration by Hosmer-Lemeshow goodness-of-fit test (all *P* \> 0.05). The calibration remains to be improved since SAPS 3 and AUS-SAPS 3 models overestimated the hospital mortality in all subgroups. This systematic overestimation of mortality has been reported in other studies.\[[@ref13][@ref14][@ref15]\] Nonetheless, groups of severe pneumonia, septic shock, and sudden death had SMR of 0.80, 0.79, and 0.82, respectively, which were distinctly higher than other groups. As expected, the use of SAPS 3 resulted in improved calibration for common severe diseases of ICU.

We determined four biomarkers as significant variables by univariate analysis and multiple logistic regression analysis. As shown above, BUN, albumin, lactate, and FT3 were related to prognosis. These biomarkers affected critical patients in certain ways though not included in the SAPS 3 score. BUN and creatinine functions are similar that both are biomarkers for acute or chronic renal damage. Systemic diseases such as serious infection, multiple organ failure, and severe acute pancreatitis can increase BUN levels, followed by a poor prognosis.\[[@ref16][@ref17]\] The level of albumin appeared negatively related with the mortality. Serum albumin is produced in the liver. Albumin is usually degraded ubiquitously, in an amount comparable to that synthesized by the liver. Clinical conditions activating an inflammatory process might repress albumin synthesis, i.e., sepsis, trauma, and massive hemorrhage.\[[@ref18]\] Besides, two of the most important determinants of acute hypoalbuminemia are hemodilution during fluid resuscitation and capillary leakage into the interstitial space in patients with a systemic inflammatory response.\[[@ref19]\] A reduction of albumin concentration usually results in decreasing blood volume, which might even cause multiple organ dysfunction when serious. Furthermore, an essential function of albumin is to neutralize toxic compounds such as oxygen radicals and nitrite peroxides, decreased albumin can make infection control more difficult. Hypoalbuminemia strongly links with mortality of critical patients.\[[@ref20]\] Lactate is the end product of anaerobic glycolysis. In situations of hypoperfusion or hypoxia, pyruvate will no longer enter into the mitochondria for aerobic metabolism, but instead, it is preferentially reduced to lactate, resulting in the accumulation of lactate in the blood.\[[@ref21]\] The International Guidelines for Management of Severe Sepsis and Septic Shock of 2012 pointed out that the mortality rate is high in septic patients with lactate ≥4 mmol/L alone. Research has shown that patients with high serum lactate levels (\>10 mmol/l) showed severe acidosis and their probability of mortality was high.\[[@ref22]\] Euthyroid sick syndrome occurs in a variety of nonthyroidal illnesses. In critical illness, many abnormalities in the pituitary--thyroid axis have been demonstrated, including attenuated TRH response, decreased TSH release, decreased level of TBG, decreased total T~4~ and T~3~ levels, low tissue uptake of thyroid hormones, and altered thyroid hormone metabolism. The syndrome has been reported in starvation, acute and chronic medical illnesses, bone marrow transplantation, surgery, trauma, and, in fact, can be seen in any severe systemic illness.\[[@ref23]\] FT3, FT4, and TSH levels were all found to be associated with higher mortality in intensive care patients.\[[@ref24][@ref25]\] Generally speaking, measurement of BUN, albumin, lactate, and FT3 levels might be useful as a predictor of mortality in intensive care patients. Those four biomarkers are expected to be included in model in the future.

The present study has potential limitations. One could criticize the study as a retrospective and single-center study, with relatively small sample size. For this reason, it is necessary to validate the SAPS 3 prognostic model in a prospective multicenter study to minimize possible biases. Another potential limitation is the fact that the study overestimated hospital mortality. We might need to customize SAPS 3 model for China using the method that other studies applied.\[[@ref10][@ref26]\]

The SAPS 3 score system exhibited satisfactory performance, even superior to APACHE II in discrimination. In predicting hospital mortality, SAPS 3 did not exhibit good calibration and overestimated hospital mortality. To improve the predictive value of the model, it might be necessary to improve the models on a regional basis.
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